Government Pharmaceutical Factories Unlikely To Satisfy Demand For Low-Cost Medicines

BMI View: Plans by the Venezuelan government to build pharmaceutical plants are unlikely to lower medicine costs for patients due to the inherent inefficiency of state-backed drugmakers and the inconsistent supply of raw materials. We expect medicine price caps, ongoing currency devaluation and general economic instability in the country will diminish profits for pharmaceutical companies, lowering the attractiveness of the

To read the full article, please choose one of the following options: